정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 765 | Recruiting | Quit Smoking Study for People Who Use E-Cigarettes | Quitting Smoking | Drug: Nicotine replacement therapy patch Drug: Nicotine replacement therapy lozenge Behavioral: Quit electronic cigarettes Behavioral: Continue electronic cigarettes |
Phase 2 | University of Vermont | OTHER | 390 | All | 18 Years ~ 29 Years | University of Vermont, Burlington, Vermont, United States |
| 764 | Recruiting | Ramipril for the Treatment of COVID-19 | COVID-19 | Drug: Ramipril 2.5 MG Oral Capsule Drug: Placebo oral capsule |
Phase 2 | University of California, San Diego, Pfizer | OTHER | 560 | All | 18 Years | University of California, San Diego, La Jolla, California, United States |
| 763 | Recruiting | Randomised Evaluation of COVID-19 Therapy | Severe Acute Respiratory Syndrome | Drug: Lopinavir-Ritonavir Drug: Corticosteroid Drug: Hydroxychloroquine Drug: Azithromycin Biological: Convalescent plasma Drug: Tocilizumab Biological: Immunoglobulin Drug: Synthetic neutralising antibodies Drug: Aspirin Drug: Colchicine Drug: Baricitinib Drug: Anakinra Drug: Dimethyl fumarate Drug: High Dose Corticosteroid Drug: Empagliflozin |
Phase 3 | University of Oxford, UK Research and Innovation, National Institute for Health Research, United Kingdom, Wellcome, Bill and Melinda Gates Foundation, Department for International Development, United Kingdom, Health Data Research UK, Medical Research Council Population Health Research Unit, NIHR Clinical Trials Unit Support Funding, NIHR Health Protection Research Unit in Emerging and Zoonotic Infections | OTHER | 45000 | All | Kumasi Center for Collaborative Research in Tropical Medicine KNUST, Kumasi, Ghana Indian Council of Medical Research, Division of Epidemiology and Communicable Diseases, New Delhi, India Eijkman Oxford Clinical Research Unit (EOCRU), Eijkman Institute for Molecular Biology, Jakarta, Indonesia Clinical Trial Unit, Oxford University Clinical Research Unit-Nepal, Patan Academy of Health Sciences, Kathmandu, Nepal Wits Health Consortium, Johannesburg, South Africa RECOVERY Sri Lanka & Pakistan, National Intensive Care Surveillance - M.O.R.U, Colombo, Sri Lanka Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom Oxford University Clinical Research Unit, Centre for Tropical Medicine, Ho Chi Minh City, Vietnam |
|
| 762 | Recruiting | Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY) | Paediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS) | Drug: Methylprednisolone sodium succinate Biological: Human normal immunoglobulin (IVIg) |
Phase 3 | University Children's Hospital Basel | OTHER | 75 | All | 44 Weeks ~ 18 Years | Cantonal Hospital Aarau, Department of Paediatrics, Aarau, Switzerland University of Basel Children's Hospital, Basel, Switzerland Ente Ospedaliero Cantonale Ticino (EOC) Pediatrica, Bellinzona, Switzerland Department of Pediatrics, University of Bern, Bern, Switzerland Department of Child, Woman and, Adolescent Medecine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland Department of Pediatrics,University Hospital of Lausanne (CHUV), Lausanne, Switzerland Department of Pediatrics, Cantonal Hospital Luzern, Luzern 16, Switzerland Children's Hospital of Eastern Switzerland, St. Gallen, Switzerland Department of Pediatrics, Cantonal Hospital Fribourg, Villars-sur-Glane, Switzerland University Children's Hospital Zuerich, Zuerich, Switzerland |
| 761 | Recruiting | Randomised Study of Plasma Exchange in Severe COVID-19 | COVID19 | Drug: OCTAPLAS | Phase 2 | University College, London | OTHER | 20 | All | 18 Years ~ 70 Years | University College London Hospital, London, United Kingdom |
| 760 | Completed | Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel | Coronavirus Infection | Drug: Emtricitabine/tenofovir disoproxil Drug: Hydroxychloroquine Drug: Placebo: Emtricitabine/tenofovir disoproxil Placebo Drug: Placebo: Hydroxychloroquine |
Phase 3 | Plan Nacional sobre el Sida (PNS), Effice Servicios Para la Investigacion S.L. | OTHER_GOV | 1002 | All | 18 Years ~ 70 Years | Hospital Universitario de Ferrol, Ferrol, A Coruna, Spain Hospital Clinico Universitario de Santiago, Santiago De Compostela, A Coruna, Spain Hospital General de Elche, Elche, Alicante, Spain Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain Hospital Sant Joan de Deu de Esplugues, Esplugues De Llobregat, Barcelona, Spain Parc Sanitari Sant Joan de Deu de Sant Boi, Sant Boi De Llobregat, Barcelona, Spain Hospital Moises Broggi, Sant Joan Despi, Barcelona, Spain Hospital Infanta Margarita, Cabra, Cordoba, Spain Hospital Insular de Las Palmas, Las Palmas De Gran Canaria, Gran Canaria, Spain Hospital Universitario de Canarias, Las Palmas De Gran Canaria, Gran Canaria, Spain Hospital de Donostia, San Sebastian, Guipuzcoa, Spain Hospital San Pedro, Logrono, La Rioja, Spain Hospital Principe de Asturias, Alcala De Henares, Madrid, Spain Hospital Fundacion de Alcorcon, Alcorcon, Madrid, Spain Hospital Colllado Villalba, Collado-Villalba, Madrid, Spain Hospital de Getafe, Getafe, Madrid, Spain Hospital Severo Ochoa, Leganes, Madrid, Spain Hospital de Mostoles, Mostoles, Madrid, Spain Hospital Rey Juan Carlos, Mostoles, Madrid, Spain Hospital Quiron Pozuelo, Pozuelo De Alarcon, Madrid, Spain Hospital de Torrejon, Torrejon De Ardoz, Madrid, Spain Hospital Infanta Elena, Valdemoro, Madrid, Spain Hospital Virgen del Castillo, Yecla, Murcia, Spain Hospital Costa del Sol, Marbella, Malaga, Spain Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain Hospital Reina Sofia, Tudela, Navarra, Spain Hospital Arnau de Vilanova, Lliria, Valencia, Spain Hospital de Araba, Alava, Vitoria, Spain Hospital General Universitario de Albacete, Albacete, Spain Centro Medico Teknon, Barcelona, Spain Hospital Clinic, Barcelona, Spain Hospital del Mar, Barcelona, Spain Hospital Dexeus, Barcelona, Spain Hospital Quiron Barcelona, Barcelona, Spain Hospital Universitario Sagrat Cor, Barcelona, Spain Hospital Universitario de Burgos, Burgos, Spain Hospital Virgen de la Luz, Cuenca, Spain Hospital Clinico San Cecilio, Granada, Spain Hospital Universitario de Leon, Leon, Spain Hospital Universitario Ramon y Cajal, Madrid, Spain Fundacion Jimenez Diaz, Madrid, Spain Hospital Clinico San Carlos, Madrid, Spain Hospital Infanta Leonor, Madrid, Spain Hospital La Princesa, Madrid, Spain Hospital Universitario 12 de Octubre, Madrid, Spain Hospital Universitario Gregorio Maranon, Madrid, Spain Hospital Universitario La Paz, Madrid, Spain Hospital Universitario Puerta de Hierro, Madrid, Spain Hospital Reina Sofia, Murcia, Spain Hospital Universitario Virgen de la Arrixaca, Murcia, Spain Hospital Virgen de la Victoria, Malaga, Spain Complejo Asistencial de Palencia, Palencia, Spain Hospital Universitario de Salamanca, Salamanca, Spain Hospital General de Segovia, Segovia, Spain Hospital Virgen del Rocio, Sevilla, Spain Hospital Virgen Macarena, Sevilla, Spain Hospital Clinico Universitario, Valencia, Spain Hospital Dr. Peset, Valencia, Spain Hospital General de Valencia, Valencia, Spain Hospital La Fe, Valencia, Spain Hospital de Valladolid, Valladolid, Spain Hospital Rio Hortega, Valladolid, Spain Hospital Lozano Blesa, Zaragoza, Spain Hospital Miguel Servet, Zaragoza, Spain Hospital Nuestra Senora de Sonsoles, Avila, Spain |
| 759 | Recruiting | Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19 | Covid19 | Drug: IV Dexamethasone Drug: Nasal Dexamethasone |
Phase 2 | Edda Sciutto Conde, Hospital General de Mexico Dr. Eduardo Liceaga, Instituto Nacional de Cardiologia Ignacio Chavez, El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | OTHER | 60 | All | 18 Years ~ 75 Years | Hospital General de Mexico Dr. Eduardo Liceaga, Mexico City, Cdmx, Mexico Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Cdmx, Mexico El Instituto Nacional de Neurologia Y Neurocirugia Manuel Velasco Suarez, Mexico City, Cdmx, Mexico |
